oncology medicine

Sorafenat 200 mg Tablets contain Sorafenib 200 mg, a targeted cancer medicine used under specialist supervision for certain cancers. Cordium Pharmaceuticals Pvt. Ltd. supports pharmaceutical export enquiries for eligible international buyers. Available for Export Enquiries: Morocco, Kenya, Singapore, Australia, Germany, France, Canada & Saudi Arabia. Sorafenat 200 mg – Key Information Brand: Sorafenat Active Ingredient: Sorafenib Strength: 200 mg Dosage Form: Tablet Category: Oncology / Targeted Therapy Prescription: Required Sorafenib targets specific kinase pathways involved in cancer-cell growth and tumor blood-vessel formation. It may be prescribed for selected cases of hepatocellular carcinoma, renal cell carcinoma, and differentiated thyroid cancer. Uses of Sorafenat 200 mg Sorafenat may be prescribed for: Liver cancer Kidney cancer Certain differentiated thyroid cancers Treatment and dosage should be determined by an oncologist based on the patient's medical condition. Side Effects Possible side effects include: Diarrhea Fatigue Skin rash Hand-foot skin reaction Nausea Loss of appetite High blood pressure Hair loss Patients experiencing severe or unusual symptoms should contact their healthcare professional promptly. Dosage & Precautions Take Sorafenat exactly as prescribed. Do not change or stop treatment without medical advice. Inform your doctor about other medicines, supplements, existing medical conditions, and any history of heart, liver, kidney, blood-pressure, or bleeding problems. International Sorafenat 200 mg Supply Cordium Pharmaceuticals Pvt. Ltd. provides export support for eligible pharmaceutical buyers in: Morocco | Kenya | Singapore | Australia | Germany | France | Canada | Saudi Arabia Supply is subject to each country's prescription, import, registration, customs, and pharmaceutical regulations. Why Choose Cordium Pharmaceuticals? India-based pharmaceutical exporter International oncology medicine supply support Professional packaging and shipment coordination Export documentation assistance Support for eligible hospitals, pharmacies and distributors Competitive international quotations FAQs 1. What is Sorafenat 200 mg? Sorafenat 200 mg is a prescription tablet containing Sorafenib, a targeted cancer therapy. 2. What is Sorafenat used for? It may be used for selected cases of liver cancer, kidney cancer, and differentiated thyroid cancer. 3. Is Sorafenat chemotherapy? Sorafenib is generally classified as a targeted cancer therapy rather than traditional chemotherapy. 4. Can I take Sorafenat without a prescription? No. It should be used only under qualified medical supervision. 5. What are common Sorafenat side effects? Diarrhea, fatigue, rash, hand-foot skin reaction, nausea, appetite loss, and high blood pressure may occur. 6. Can Cordium Pharmaceuticals supply Sorafenat internationally? Cordium Pharmaceuticals Pvt. Ltd. accepts international supply enquiries subject to applicable laws and import requirements.

Sorafenib 200MG Tablets contain Sorafenib, an oral targeted anticancer medicine used under specialist supervision for certain liver, kidney, and differentiated thyroid cancers. Sorafenib 200MG information is relevant to patients seeking treatment options in Washington, New York, California, Dubai, Abu Dhabi, London, Manchester, Birmingham, Johannesburg, Cape Town, and Durban. Sorafenib 200MG Uses Sorafenib may be prescribed for: Liver cancer (HCC) – certain advanced or unresectable cases. Kidney cancer (RCC) – selected advanced cases. Differentiated thyroid cancer – certain progressive or metastatic cases that are not responsive to radioactive iodine. How Sorafenib Works Sorafenib is a tyrosine kinase inhibitor. It blocks multiple pathways involved in cancer-cell growth and tumor blood-vessel formation, helping slow progression of certain cancers. Benefits Targeted anticancer treatment Helps slow tumor growth May inhibit tumor-supporting blood-vessel formation Convenient oral tablet Used as part of specialist oncology treatment Dosage & Administration For certain approved adult indications, the labeled starting regimen is 400MG twice daily, equivalent to two 200MG tablets twice daily. Your oncologist may adjust the dose depending on your condition and side effects. Sorafenib is generally taken without food. Take it exactly as prescribed and do not change the dose without medical advice. Side Effects Common side effects may include: Diarrhea Fatigue Nausea Loss of appetite Skin rash Hair thinning Hand-foot skin reaction Increased blood pressure Seek urgent medical attention for severe bleeding, chest pain, breathing difficulties, severe abdominal pain, serious skin reactions, or yellowing of the skin or eyes. Sorafenib 200MG by Location USA: Washington, New York & California UAE: Dubai & Abu Dhabi UK: London, Manchester & Birmingham South Africa: Johannesburg, Cape Town & Durban Sorafenib should be obtained through authorized pharmaceutical and healthcare channels. Prescription, availability, and import requirements vary by location. FAQs What is Sorafenib 200MG? Sorafenib 200MG is a targeted anticancer tablet used for certain liver, kidney, and differentiated thyroid cancers. Is Sorafenib chemotherapy? It is a targeted therapy/tyrosine kinase inhibitor, rather than traditional cytotoxic chemotherapy. What is the usual dose? For certain approved indications, the labeled starting regimen is 400MG twice daily. The treating doctor may modify the dose. Can Sorafenib cause high blood pressure? Yes. Blood-pressure monitoring may be required during treatment. Can Sorafenib cause hand-foot syndrome? Yes. Redness, pain, swelling, burning, peeling, or blistering of the palms and soles may occur. Is Sorafenib available in these cities? Sorafenib may be available through regulated pharmaceutical channels in the listed cities, subject to local prescription and regulatory requirements.

Soranib 200MG Tablets contain Sorafenib 200MG, a targeted anticancer medicine belonging to the tyrosine kinase inhibitor class. It is prescribed by oncologists for certain advanced cancers, including liver cancer, kidney cancer, and differentiated thyroid cancer. Soranib 200MG should only be used with a valid prescription and under the supervision of a qualified healthcare professional. Soranib 200MG Uses Soranib 200MG may be prescribed for: Hepatocellular carcinoma (HCC) – certain advanced liver cancers. Renal cell carcinoma (RCC) – certain advanced kidney cancers. Differentiated thyroid cancer – selected locally advanced or metastatic cases that have progressed despite radioactive iodine treatment. How Does Soranib Work? Soranib contains sorafenib, which blocks several kinase pathways involved in cancer-cell growth and tumor blood-vessel formation. This can help slow the progression of certain cancers. Benefits of Soranib 200MG Potential benefits include: Targeted treatment for specific cancers. Helps inhibit cancer-cell growth. May reduce signals that support tumor blood-vessel development. Oral treatment option. Used in specialist oncology treatment plans. Treatment response varies between patients and should be evaluated by an oncologist. Soranib 200MG Dosage For certain approved adult indications, the labeled sorafenib starting regimen is 400MG twice daily, equivalent to two 200MG tablets twice daily. However, the dose may be reduced or interrupted by the treating physician depending on side effects and individual patient factors. Do not change the dosage yourself. Soranib is generally taken without food and should be taken exactly as prescribed. Swallow the tablets with water. Soranib 200MG Side Effects Possible side effects include: Diarrhea Fatigue Nausea Loss of appetite Weight loss Skin rash Itching Hair thinning or hair loss Hand-foot skin reaction Increased blood pressure Muscle or joint discomfort Serious Side Effects Contact a healthcare professional urgently for severe bleeding, chest pain, difficulty breathing, severe abdominal pain, serious skin reactions, fainting, significant vision changes, or yellowing of the skin or eyes. Soranib 200MG Precautions Tell your doctor if you have: Heart disease High blood pressure Liver or kidney problems Bleeding disorders Upcoming surgery Allergies Other medical conditions Also inform your doctor about all prescription medicines, supplements, and herbal products you use. Soranib 200MG in USA, UK, UAE & South Africa Soranib/Sorafenib 200MG may be used in specialist oncology care in the USA, UK, UAE, and South Africa for appropriate indications. Product availability, prescription requirements, registration, and import regulations vary by country. Patients should obtain this prescription medicine through legitimate and authorized pharmaceutical channels. FAQs What is Soranib 200MG? Soranib 200MG contains sorafenib, a targeted anticancer medicine used for certain liver, kidney, and thyroid cancers. What is Soranib 200MG used for? It may be prescribed for certain advanced liver cancer, kidney cancer, and differentiated thyroid cancer patients. Is Soranib chemotherapy? Soranib is a targeted therapy known as a tyrosine kinase inhibitor, rather than conventional cytotoxic chemotherapy. What is the usual Soranib dosage? For certain approved indications, the standard starting regimen is 400MG twice daily, but your doctor may adjust the dose according to your condition and tolerance. Can Soranib cause high blood pressure? Yes. Increased blood pressure is a recognized side effect, so monitoring may be required. Can Soranib cause hand-foot syndrome? Yes. Redness, pain, swelling, burning, peeling, or blistering of the palms and soles can occur. Can Soranib be taken during pregnancy? Sorafenib may harm an unborn baby. Discuss pregnancy and contraception with your healthcare provider. Is Soranib available in the USA, UK, UAE and South Africa? Sorafenib products may be available through regulated pharmaceutical channels in these countries, subject to local prescription and regulatory requirements.

Rucaparib Tablets 200mg, 250mg and 300mg are oral targeted anticancer medicines belonging to the PARP inhibitor class. Rucaparib may be prescribed for selected patients with certain ovarian, fallopian tube, primary peritoneal and BRCA-mutated prostate cancers. Cordium Pharmaceuticals Pvt Ltd is an India-based pharmaceutical exporter providing oncology and specialty medicines to authorized international buyers. Rucaparib Tablets Uses Rucaparib may be prescribed under specialist supervision for: Certain ovarian cancers Fallopian tube cancer Primary peritoneal cancer BRCA-mutated metastatic castration-resistant prostate cancer Rucaparib inhibits PARP enzymes involved in DNA repair, which can increase DNA damage in susceptible cancer cells. Rucaparib 200mg, 250mg & 300mg Benefits Targeted PARP inhibitor treatment Oral tablet formulation Used for selected BRCA-associated cancers Multiple strengths available Suitable for physician-directed dose adjustments Rucaparib Dosage Rucaparib dosage depends on the cancer indication, previous treatment, biomarker status, kidney and liver function, and individual treatment tolerance. For certain approved adult indications, a commonly recommended regimen is 600mg twice daily, with or without food. The 200mg, 250mg and 300mg tablets may be used for physician-directed dose modifications. Patients should take Rucaparib only as prescribed and should not change the dose without medical advice. Rucaparib Side Effects Common side effects may include: Nausea and vomiting Diarrhea or constipation Abdominal discomfort Fatigue and weakness Loss of appetite Taste changes Mouth sores Rucaparib can also cause serious blood-related adverse effects and rare MDS/AML. Regular medical monitoring is important. Affordable Rucaparib Tablets Supply Cordium Pharmaceuticals Pvt Ltd provides competitive pharmaceutical sourcing and international export support for Rucaparib Tablets 200mg, 250mg and 300mg. We receive pharmaceutical supply inquiries from: Morocco | Kenya | Singapore | Australia | Germany | France | Canada | Saudi Arabia Our services can support authorized: Pharmaceutical distributors Hospitals Pharmacies Licensed importers Healthcare procurement organizations Pricing and availability may vary according to order quantity, destination, documentation, shipping requirements and local regulations. Why Choose Cordium Pharmaceuticals Pvt Ltd? India-based pharmaceutical exporter Oncology and specialty medicine portfolio Competitive international pricing Global export support Export documentation assistance Support for authorized pharmaceutical buyers Professional pharmaceutical sourcing Frequently Asked Questions What are Rucaparib Tablets used for? Rucaparib is a targeted anticancer medicine used for selected cancer indications, including certain ovarian and BRCA-mutated prostate cancers. What strengths of Rucaparib are available? Rucaparib tablets are available in 200mg, 250mg and 300mg strengths. Is Rucaparib a chemotherapy medicine? Rucaparib is an oral targeted anticancer medicine classified as a PARP inhibitor. Can Rucaparib be purchased without a prescription? Rucaparib is a prescription anticancer medicine and should be used under qualified medical supervision. Does Cordium Pharmaceuticals supply Rucaparib internationally? Cordium Pharmaceuticals provides international pharmaceutical export support for authorized buyers, subject to destination-country regulations. Conclusion Rucaparib Tablets 200mg, 250mg & 300mg are targeted PARP inhibitor medicines used for selected cancer patients. Appropriate medical evaluation, biomarker testing, individualized dosing and regular monitoring are essential. Cordium Pharmaceuticals Pvt Ltd provides affordable and reliable pharmaceutical sourcing support from India for authorized buyers in Morocco, Kenya, Singapore, Australia, Germany, France, Canada and Saudi Arabia, subject to applicable regulations.

Rucaparib Tablets 200mg, 250mg and 300mg are targeted oral anticancer medicines belonging to the PARP inhibitor class. Rucaparib may be prescribed for selected patients with certain ovarian, fallopian tube, primary peritoneal and BRCA-mutated prostate cancers. Cordium Pharmaceuticals Pvt Ltd is an India-based pharmaceutical exporter providing oncology medicines to authorized international buyers and healthcare procurement organizations. Rucaparib Tablets Uses Rucaparib may be used under specialist medical supervision for: Certain ovarian cancers Fallopian tube cancer Primary peritoneal cancer BRCA-mutated metastatic castration-resistant prostate cancer Rucaparib works by inhibiting PARP enzymes involved in DNA repair. This can increase DNA damage in susceptible cancer cells. Rucaparib 200mg, 250mg & 300mg Benefits Targeted PARP inhibitor therapy Oral tablet administration Used for selected BRCA-associated cancers Multiple strengths available for physician-directed treatment adjustments Suitable for selected patients based on medical and biomarker assessment Rucaparib Dosage Rucaparib dosage is determined by an oncologist according to the patient's cancer type, previous treatment, biomarker status and overall health. For certain approved adult indications, the commonly recommended dose is 600mg twice daily, with or without food. The 200mg, 250mg and 300mg tablets may be used when a physician recommends dose modification. Do not change the prescribed dose or discontinue treatment without medical advice. Rucaparib Side Effects Common side effects may include: Nausea and vomiting Diarrhea or constipation Abdominal discomfort Fatigue and weakness Loss of appetite Taste changes Mouth sores Rucaparib can also cause serious blood-related adverse effects and rare MDS/AML. Regular medical monitoring is important. Rucaparib Tablets Best Price & Global Supply Cordium Pharmaceuticals Pvt Ltd offers competitive pricing and international supply support for Rucaparib Tablets 200mg, 250mg and 300mg to authorized pharmaceutical buyers. We support inquiries from: USA UK UAE South Africa Supply, pricing, documentation, prescription requirements and import regulations may vary by destination. Buyers should comply with the applicable laws of their country. Why Choose Cordium Pharmaceuticals Pvt Ltd? India-based pharmaceutical exporter Oncology and specialty medicine portfolio Competitive international pricing Global pharmaceutical supply support Export documentation assistance Support for authorized distributors, hospitals and pharmacies FAQs About Rucaparib Tablets What are Rucaparib Tablets used for? Rucaparib is used for selected cancer indications, including certain ovarian and BRCA-mutated prostate cancers. What strengths are available? Rucaparib tablets are available in 200mg, 250mg and 300mg strengths. Is Rucaparib a chemotherapy medicine? Rucaparib is an oral targeted anticancer medicine classified as a PARP inhibitor. Can I buy Rucaparib without a prescription? Rucaparib is a prescription anticancer medicine and should be used under qualified medical supervision. Where does Cordium Pharmaceuticals export Rucaparib? Cordium Pharmaceuticals provides international pharmaceutical export support, including inquiries from the USA, UK, UAE and South Africa, subject to local regulations. Conclusion Rucaparib Tablets 200mg, 250mg & 300mg are targeted anticancer medicines used for selected patients. Appropriate medical evaluation, biomarker testing, individualized dosing and monitoring are essential. Cordium Pharmaceuticals Pvt Ltd provides competitive pharmaceutical sourcing and global export support from India for authorized healthcare and pharmaceutical buyers.

Relugolix 120 mg Tablets contain Relugolix, an oral GnRH receptor antagonist used as androgen-deprivation therapy for appropriate adult patients with advanced prostate cancer. It works by reducing testosterone production, helping control prostate cancer that depends on androgen signaling. Relugolix 120 mg – Key Details Active Ingredient: Relugolix Strength: 120 mg Form: Oral tablet Drug Class: GnRH receptor antagonist Main Use: Advanced prostate cancer Prescription: Required Benefits & Uses Relugolix 120 mg may: Reduce testosterone levels. Help control androgen-dependent prostate cancer. Provide an oral alternative to injectable androgen-deprivation therapy. Offer convenient once-daily maintenance treatment. Dosage & Administration The approved prostate-cancer regimen generally starts with a 360 mg loading dose on Day 1, followed by 120 mg once daily from Day 2. It can generally be taken with or without food. Take it at approximately the same time every day and follow your doctor's instructions. Do not change the dosage or stop treatment without medical advice. Side Effects Possible side effects include: Hot flashes Fatigue Sweating Muscle or joint pain Decreased libido Sexual-function changes Weight gain Diarrhea or constipation Tell your healthcare professional about severe or persistent symptoms. Relugolix may also affect heart rhythm in some patients. Precautions Inform your doctor if you have heart or rhythm problems, liver disease, diabetes, electrolyte abnormalities or medicine allergies. Provide a complete list of your medicines and supplements because drug interactions can occur. Relugolix 120 mg Availability Relugolix 120 mg Tablets may be available through appropriate pharmaceutical supply channels in Morocco, Kenya, Singapore, Australia, Germany, France, Canada and Saudi Arabia, subject to local registration, prescription and import regulations. Patients should obtain prescription medicines through licensed healthcare professionals and authorized pharmacies. Frequently Asked Questions What is Relugolix 120 mg used for? Relugolix 120 mg is used as androgen-deprivation therapy for appropriate adult patients with advanced prostate cancer. How does Relugolix work? It blocks GnRH receptors and reduces testosterone production, helping control hormone-dependent prostate cancer. What is the usual dosage? The approved regimen generally begins with 360 mg on Day 1, followed by 120 mg once daily from Day 2. Can Relugolix be taken with food? Yes. It can generally be taken with or without food. What are common side effects? Common effects may include hot flashes, fatigue, musculoskeletal pain, decreased libido, weight gain, diarrhea and constipation. Is Relugolix a prescription medicine? Yes. It should be used only under the supervision of a qualified healthcare professional. Where can Relugolix 120 mg be obtained? Availability varies by country. Patients should check with licensed pharmacies and healthcare providers in Morocco, Kenya, Singapore, Australia, Germany, France, Canada or Saudi Arabia.

Relugonat 120 mg Tablets contain Relugolix, a GnRH receptor antagonist used as androgen-deprivation therapy for advanced prostate cancer in adult patients. It works by reducing testosterone production, helping control prostate cancer that depends on androgen signaling. Key Information Active Ingredient: Relugolix 120 mg Dosage Form: Tablet Therapeutic Class: GnRH receptor antagonist Main Use: Advanced prostate cancer Route: Oral Benefits & Uses Relugonat 120 mg may: Lower testosterone levels. Help slow the growth of hormone-sensitive prostate cancer. Provide an oral alternative to injectable androgen-deprivation therapy. Offer convenient once-daily maintenance treatment. It should be used only according to a doctor's prescription. Relugonat 120 mg Dosage For the approved prostate cancer regimen, treatment generally begins with a 360 mg loading dose on Day 1, followed by 120 mg once daily from Day 2. It can be taken with or without food and should be taken around the same time each day. Do not change the dose or stop treatment without medical advice. How Does Relugolix Work? Relugolix blocks GnRH receptors, reducing the hormonal signals that stimulate testosterone production. Lower testosterone can help control androgen-dependent prostate cancer. Side Effects Possible side effects include: Hot flashes and sweating Fatigue Muscle, joint, back or bone pain Reduced libido or sexual-function changes Weight gain Diarrhea or constipation Changes in blood glucose or lipids Contact a healthcare professional if side effects are severe or persistent. Relugolix may also affect heart rhythm in susceptible patients. Precautions Tell your doctor if you have heart rhythm problems, cardiovascular disease, liver problems, diabetes or electrolyte abnormalities. Inform your healthcare professional about all medicines and supplements you take because drug interactions may occur. Relugonat 120 mg in USA, UK, UAE & South Africa Relugonat (Relugolix) 120 mg is intended for patients requiring appropriate androgen-deprivation therapy for advanced prostate cancer. Availability, prescribing requirements and pharmaceutical regulations differ between the USA, UK, UAE and South Africa. Patients should obtain prescription medicines through authorized healthcare channels and follow local regulations. FAQs What is Relugonat 120 mg? Relugonat 120 mg contains Relugolix and is used as androgen-deprivation therapy for advanced prostate cancer. What is Relugolix 120 mg used for? It is used to reduce testosterone levels in adults with advanced prostate cancer. How should Relugolix 120 mg be taken? The usual regimen starts with a 360 mg loading dose followed by 120 mg once daily, as prescribed by a healthcare professional. Can Relugolix be taken with food? Yes, it can generally be taken with or without food. What are common Relugolix side effects? Hot flashes, fatigue, musculoskeletal pain, sexual-function changes, weight gain, diarrhea and constipation can occur. Is Relugonat 120 mg available internationally? Availability varies by country. Patients should check with licensed healthcare providers or pharmacies regarding local availability and requirements.

Regorafenib 40 mg Tablets are oral targeted anticancer medicines used under qualified medical supervision for certain advanced or metastatic cancers. Regorafenib belongs to the multikinase inhibitor class and works by targeting pathways involved in cancer-cell growth and tumor blood-vessel formation. Regorafenib 40 mg Tablets Regorafenib is a prescription oncology medicine that may be used for eligible patients with: Metastatic colorectal cancer (CRC) Advanced or metastatic gastrointestinal stromal tumor (GIST) Certain hepatocellular carcinoma (HCC) Treatment suitability depends on the cancer type, previous treatments, overall health, and the treating oncologist's assessment. Benefits of Regorafenib 40 mg Regorafenib may help: Slow the growth of certain cancer cells. Block pathways involved in tumor progression. Inhibit blood-vessel formation that supports tumor growth. Provide an oral targeted treatment option. Support treatment of specific advanced cancers following previous therapies. Uses of Regorafenib 40 mg Colorectal Cancer Regorafenib may be prescribed for certain metastatic colorectal cancer patients whose disease has progressed following previous treatments. Gastrointestinal Stromal Tumor (GIST) It may be used for eligible patients with advanced or metastatic GIST after previous targeted treatments. Hepatocellular Carcinoma (HCC) Regorafenib may be prescribed for selected patients with liver cancer following previous sorafenib treatment. Regorafenib 40 mg Dosage Regorafenib dosage must be determined by an oncologist. A commonly recommended adult starting regimen is 160 mg once daily for 21 consecutive days, followed by 7 days without treatment. Doctors may reduce, interrupt, or discontinue treatment depending on tolerability, side effects, liver function, and the patient's clinical condition. Regorafenib is generally taken after a low-fat meal and swallowed whole with water. Do not crush or chew the tablets. Side Effects Common side effects may include: Fatigue Diarrhea Reduced appetite Weight loss Nausea Mouth sores Hand-foot skin reaction Increased blood pressure Voice changes Regorafenib can also cause serious adverse reactions, including liver injury, severe bleeding, heart problems, severe skin reactions, and gastrointestinal complications. Contact a healthcare professional promptly if serious or unusual symptoms occur. Regorafenib Availability in International Markets Regorafenib 40 mg may be sought by patients and healthcare providers in Morocco, Kenya, Singapore, Australia, Germany, France, Canada, and Saudi Arabia. However, pharmaceutical availability, registration, prescription requirements, import rules, and approved indications vary by country. Patients should obtain Regorafenib only through an authorized and legally compliant pharmaceutical supply channel and follow local regulations. Morocco & Kenya Patients should consult local healthcare professionals regarding prescription requirements and legal import or supply procedures. Singapore & Australia Regorafenib is a prescription oncology medicine. Supply and use should comply with applicable national pharmaceutical regulations. Germany & France Patients should follow local prescription, pharmacy, reimbursement, and medicine-supply requirements applicable in their country. Canada & Saudi Arabia Availability and dispensing requirements may vary. Patients should consult an authorized healthcare professional or licensed pharmaceutical supplier. Important Precautions Before taking Regorafenib, inform your doctor if you have: Liver disease High blood pressure Heart problems Bleeding disorders Upcoming surgery Allergies to medicines Other ongoing medications Regular monitoring may include blood pressure, liver-function tests, and assessment of treatment-related side effects. FAQs What is Regorafenib 40 mg used for? Regorafenib is used for certain advanced or metastatic colorectal cancer, GIST, and hepatocellular carcinoma in eligible patients. Is Regorafenib a chemotherapy medicine? Regorafenib is an oral targeted anticancer medicine and multikinase inhibitor. It works differently from traditional cytotoxic chemotherapy. What is the usual Regorafenib dose? A commonly recommended adult starting regimen is 160 mg once daily for 21 days followed by 7 days off. The treating oncologist may adjust this regimen. Can Regorafenib be taken with food? Yes. It is generally taken after a low-fat meal and should be taken according to the prescribing instructions. Does Regorafenib require monitoring? Yes. Doctors may monitor liver function, blood pressure, treatment response, and potential adverse effects. Is Regorafenib available in Morocco, Kenya, Singapore, Australia, Germany, France, Canada and Saudi Arabia? Availability and legal supply requirements vary by country. Patients should check with an authorized healthcare professional or licensed pharmaceutical supplier.

Regorafenib 40 mg Tablets are oral targeted anticancer medicines used under specialist medical supervision for certain advanced or metastatic cancers. Regorafenib is a multikinase inhibitor that blocks proteins involved in cancer-cell growth and tumor blood-vessel formation. What is Regorafenib 40 mg? Regorafenib 40 mg is a prescription medicine that may be used for eligible patients with: Metastatic colorectal cancer (CRC) Advanced or metastatic gastrointestinal stromal tumor (GIST) Certain hepatocellular carcinoma (HCC) Treatment depends on the cancer type, previous therapies, overall health, and the oncologist's assessment. Benefits of Regorafenib 40 mg Regorafenib may help: Slow the growth of certain cancer cells. Inhibit pathways involved in tumor progression. Reduce the formation of blood vessels that support tumors. Provide an oral targeted treatment option for eligible patients. Treat certain cancers after previous therapies have stopped working or are no longer suitable. Uses of Regorafenib 40 mg Colorectal Cancer Regorafenib may be prescribed for certain metastatic colorectal cancer patients following previous treatments. Gastrointestinal Stromal Tumor It may be used for advanced or metastatic GIST after previous treatment with other targeted therapies. Hepatocellular Carcinoma Regorafenib may be prescribed for selected patients with liver cancer following previous sorafenib treatment. Regorafenib 40 mg Dosage The dose must be prescribed by an oncologist. A commonly recommended adult starting regimen is 160 mg once daily (four 40 mg tablets) for 21 days, followed by 7 days without treatment. Doctors may reduce or interrupt the dose depending on side effects, liver function, and individual treatment response. Regorafenib is generally taken after a low-fat meal and should be swallowed whole with water. Do not crush or chew the tablets. Side Effects of Regorafenib Possible side effects include: Fatigue Diarrhea Reduced appetite Weight loss Nausea Mouth sores Hand-foot skin reaction Increased blood pressure Voice changes Regorafenib can also cause serious reactions, including liver injury, severe bleeding, heart problems, severe skin reactions, and gastrointestinal complications. Seek medical attention for severe or unusual symptoms. Regorafenib in USA, UK, UAE & South Africa Regorafenib is a prescription oncology medicine, and its availability, approved indications, prescribing requirements, and regulatory status may vary between countries. Patients in the USA, UK, UAE, and South Africa should consult a qualified oncologist or authorized healthcare professional before starting treatment and follow the applicable local regulations. Important Precautions Before taking Regorafenib, inform your doctor if you have liver disease, high blood pressure, heart problems, bleeding disorders, or upcoming surgery. Tell your healthcare professional about all prescription medicines, over-the-counter medicines, vitamins, and supplements you take. Regular monitoring, including liver-function and blood-pressure checks, may be required. FAQs What is Regorafenib 40 mg used for? It is used for certain advanced or metastatic colorectal cancer, GIST, and hepatocellular carcinoma in eligible patients. Is Regorafenib chemotherapy? Regorafenib is an oral targeted anticancer medicine and a multikinase inhibitor. It works differently from traditional chemotherapy. What is the usual dose? The commonly recommended starting regimen is 160 mg once daily for 21 days followed by 7 days off. The treating oncologist may adjust the dose. Can Regorafenib be taken with food? Yes. It is generally taken after a low-fat meal. Follow your doctor's specific instructions. Does Regorafenib require monitoring? Yes. Doctors may monitor liver function, blood pressure, treatment response, and possible side effects. Can I change or stop the dose myself? No. Dose changes or treatment interruptions should only be made under medical supervision. Conclusion Regorafenib 40 mg Tablets are an oral targeted cancer treatment for selected patients with certain advanced or metastatic cancers. Because treatment can cause significant side effects, Regorafenib should be taken only with a valid prescription and under appropriate oncology supervision. Medical Disclaimer: This information is for educational purposes and does not replace professional medical advice. Always follow your doctor's instructions and the approved prescribing information applicable in your country.

Regonat 40 mg Tablets contain Regorafenib, an oral targeted cancer medicine used under specialist supervision for certain advanced or metastatic cancers. Regorafenib is a multikinase inhibitor that can help slow cancer growth and progression. What is Regonat 40 mg? Regonat 40 mg contains Regorafenib 40 mg. It works by blocking specific proteins involved in cancer-cell growth and the formation of blood vessels that supply tumors. Composition: Regorafenib 40 mg Form: Oral tablet Drug class: Multikinase inhibitor Use: Prescription oncology medicine Benefits of Regonat 40 mg Regonat (Regorafenib) may be prescribed to: Help slow the growth of certain cancer cells. Treat certain metastatic colorectal cancers after previous treatments. Treat advanced or metastatic gastrointestinal stromal tumors (GIST). Treat certain hepatocellular carcinoma (HCC) after previous sorafenib treatment. Provide an oral targeted-treatment option for eligible patients. Uses of Regonat 40 mg Tablets Regorafenib is commonly used for specific approved cancer indications, including: Colorectal Cancer Used for certain metastatic colorectal cancer patients whose disease has progressed following previous treatments. Gastrointestinal Stromal Tumor (GIST) Used for advanced or metastatic GIST after previous treatment with other kinase inhibitors. Hepatocellular Carcinoma Used for certain patients with liver cancer who have previously received sorafenib. Regonat 40 mg Dosage The dosage should always be determined by an oncologist based on the patient's cancer type, previous treatment, medical condition, liver function, and tolerance. A commonly recommended adult starting regimen is 160 mg once daily (four 40 mg tablets) for 21 consecutive days, followed by 7 days without treatment, making one 28-day treatment cycle. Doctors may reduce or interrupt the dose depending on side effects and individual response. How to Take Regonat Take exactly as prescribed by your doctor. Usually take it once daily after a low-fat meal. Swallow tablets whole with water. Do not crush, chew, or break the tablets. Avoid grapefruit and grapefruit juice unless your healthcare professional advises otherwise. Never take an extra dose for a missed dose. Regonat 40 mg Side Effects Common side effects may include: Tiredness or weakness Diarrhea Loss of appetite Weight loss Nausea Mouth sores Hand-foot skin reaction Increased blood pressure Hoarseness or voice changes Regorafenib can also cause serious side effects, including liver injury, severe bleeding, heart problems, severe skin reactions, and gastrointestinal complications. Contact your doctor immediately if you experience yellow skin or eyes, dark urine, unusual bleeding, severe abdominal pain, chest pain, or other serious symptoms. Precautions Tell your doctor before using Regonat if you have: Liver problems High blood pressure Heart disease Bleeding disorders A planned surgery Any medication allergies Inform your healthcare professional about all medicines, supplements, and herbal products you take because Regorafenib can interact with other medicines. Regular medical monitoring, including blood pressure and liver-function tests, may be necessary during treatment. Frequently Asked Questions What is Regonat 40 mg used for? Regonat contains Regorafenib and is used for certain advanced or metastatic colorectal cancer, GIST, and hepatocellular carcinoma. Is Regonat a chemotherapy medicine? Regorafenib is an oral targeted anticancer medicine classified as a multikinase inhibitor. It works differently from traditional chemotherapy drugs. What is the usual dose of Regorafenib? The commonly recommended starting regimen is 160 mg once daily for 21 days followed by 7 days off. However, the dose may be modified by the treating oncologist. Can Regonat be taken with food? Yes. Regorafenib is generally taken after a low-fat meal. Follow your doctor's instructions regarding diet and medicines. Does Regonat affect the liver? Yes. Regorafenib may cause serious liver problems, so liver-function monitoring is important during treatment. What if I miss a dose? Follow your doctor's instructions. Do not take two doses on the same day to compensate for a missed dose. Can I stop Regonat without consulting my doctor? No. Do not stop, restart, or change the dosage without consulting your oncologist. Conclusion Regonat (Regorafenib) 40 mg Tablets are an oral targeted cancer treatment used for specific advanced or metastatic cancers. Because Regorafenib can cause significant side effects and drug interactions, treatment should be prescribed and monitored by a qualified oncology professional. Medical Disclaimer: This content is for educational purposes only and does not replace professional medical advice. Regonat 40 mg should be used only with a valid prescription and under appropriate medical supervision.

Knilonat Capsules (Nilotinib) 150mg and 200mg are targeted cancer medicines used under specialist medical supervision for certain patients with Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CML). Nilotinib belongs to the tyrosine kinase inhibitor (TKI) class and works by inhibiting the abnormal BCR-ABL protein involved in the growth of leukemia cells. Knilonat 150mg & 200mg Uses Knilonat contains Nilotinib, which may be prescribed for eligible patients with Ph+ CML, depending on their disease phase, previous treatment and medical condition. It may be used for: Newly diagnosed Ph+ CML in the chronic phase CML in patients who are resistant or intolerant to certain previous treatments Selected CML patients requiring targeted BCR-ABL inhibition Treatment should always be prescribed and monitored by a qualified hematologist or oncologist. Benefits of Nilotinib Nilotinib offers targeted treatment by blocking BCR-ABL tyrosine kinase. Potential benefits include: Helps control abnormal leukemia-cell growth Provides targeted treatment for Ph+ CML Available in 150mg and 200mg capsule strengths Oral treatment option May help patients achieve important hematologic, cytogenetic and molecular responses when appropriately prescribed The choice of strength and treatment schedule depends on the individual patient's condition and previous therapy. How to Take Knilonat Capsules Nilotinib should be taken exactly as prescribed by your doctor. It is generally taken on an empty stomach. Patients are commonly advised to avoid food for at least 2 hours before taking nilotinib and for at least 1 hour afterward. Do not change the dose, stop treatment or take additional capsules without medical advice. Avoid grapefruit and grapefruit juice because they can affect nilotinib levels. Tell your healthcare professional about all medicines, vitamins and supplements you take. Knilonat Side Effects Like other cancer medicines, Nilotinib can cause side effects. Possible side effects include: Headache Nausea Fatigue Rash or itching Muscle or joint pain Abdominal discomfort Low blood-cell counts Changes in liver or pancreatic blood tests Changes in bilirubin levels Nilotinib can also cause potentially serious effects, including QT-interval prolongation and abnormal heart rhythms, cardiovascular events, pancreatitis, liver toxicity and electrolyte abnormalities. Seek urgent medical attention for symptoms such as fainting, severe chest pain, severe breathing difficulty or symptoms suggesting a serious allergic or cardiac reaction. Knilonat Nilotinib in USA, UK, UAE & South Africa Patients searching for Knilonat 150mg and 200mg or Nilotinib for CML in the USA, UK, UAE and South Africa should obtain the medicine through appropriate prescription and regulatory channels. Availability, prescribing requirements, approved indications and import regulations can differ between countries. Patients should consult a qualified healthcare professional before using Nilotinib. Frequently Asked Questions What is Knilonat 150mg? Knilonat 150mg contains Nilotinib, a tyrosine kinase inhibitor used for appropriate patients with Philadelphia chromosome-positive CML. What is Knilonat 200mg used for? Knilonat 200mg contains Nilotinib and may be prescribed for eligible CML patients. The appropriate strength is determined by the treating specialist. Is Nilotinib chemotherapy? Nilotinib is a targeted tyrosine kinase inhibitor, rather than conventional cytotoxic chemotherapy. It specifically targets BCR-ABL tyrosine kinase. Can Nilotinib be taken with food? Nilotinib is generally taken on an empty stomach. Follow the exact instructions provided by your doctor and the applicable product information. What are the common side effects of Nilotinib? Common effects may include headache, nausea, fatigue, rash, itching, muscle pain, abdominal discomfort and changes in blood counts. Can I stop taking Knilonat when I feel better? No. Do not stop Nilotinib without speaking with your treating specialist. Treatment decisions should be based on your medical response and monitoring results. Does Nilotinib require a prescription? Yes. Nilotinib is a prescription oncology medicine that should be used under appropriate medical supervision. Why Choose a Reliable Pharmaceutical Supplier? When sourcing oncology medicines, buyers should verify: Product authenticity Manufacturer and batch information Expiry date Proper packaging and storage Required prescription or import documentation Compliance with destination-country regulations

Buy Olpaza (Olaparib) Tablets 100mg/150mg at Affordable Price from India Cordium Pharmaceuticals Pvt Ltd is a trusted pharmaceutical exporter and global supplier of Olpaza (Olaparib) Tablets 100mg and 150mg from India. We provide high-quality oncology medicines with reliable international supply solutions for hospitals, pharmacies, distributors, and personal import requirements in the UAE, UK, and South Africa. Olpaza contains Olaparib, a targeted cancer therapy belonging to the PARP inhibitor class. It works by blocking PARP enzymes involved in DNA repair, helping to prevent cancer cells with specific genetic mutations from repairing themselves. Olpaza (Olaparib) Tablets 100mg & 150mg Overview Product Name: Olpaza Tablets Active Ingredient: Olaparib Strength Available: 100mg & 150mg Tablets Category: Oncology / Targeted Cancer Therapy Therapeutic Class: PARP Inhibitor Olaparib tablets are used under specialist medical supervision for certain cancers associated with BRCA mutations and homologous recombination repair (HRR) deficiencies. Approved uses may include ovarian cancer, breast cancer, pancreatic cancer, and prostate cancer depending on regulatory guidelines and patient condition. Olpaza Tablets Export Supply in UAE, UK & South Africa Cordium Pharmaceuticals Pvt Ltd offers Olaparib Tablets export supply with: Competitive international pricing Quality-assured oncology medicines Export documentation support Secure pharmaceutical packaging Supply for hospitals and pharmacies Assistance for international buyers We support medicine supply requirements in: 🇦🇪 Olpaza Tablets in UAE We provide Olaparib 100mg and 150mg tablets supply solutions for UAE-based pharmacies, healthcare providers, and authorized importers. 🇬🇧 Olpaza Tablets in UK Our export services help UK healthcare suppliers and pharmaceutical buyers source oncology medicines from India. 🇿🇦 Olpaza Tablets in South Africa We provide reliable Olaparib tablet export solutions for South African distributors and healthcare organizations. Uses of Olpaza (Olaparib) Tablets Olaparib tablets may be prescribed for: BRCA-mutated ovarian cancer Fallopian tube and primary peritoneal cancer Certain HER2-negative breast cancers with BRCA mutations BRCA-mutated pancreatic cancer Certain metastatic prostate cancers with DNA repair gene mutations Treatment selection depends on genetic testing, cancer type, previous therapies, and physician recommendations. Benefits of Olpaza (Olaparib) Tablets Targeted therapy approach for specific cancer mutations Oral tablet formulation for convenient administration Helps block cancer cell DNA repair mechanisms Used as maintenance therapy in selected cancer patients Available in multiple strengths (100mg and 150mg) Olpaza Tablets Dosage Information The dosage of Olaparib depends on: Cancer type Genetic mutation status Previous treatments Patient health condition Doctors commonly determine the appropriate strength and duration of therapy. Do not change dosage without medical advice. Possible Side Effects of Olpaza (Olaparib) Common side effects may include: Nausea Fatigue Vomiting Loss of appetite Anemia Low blood cell counts Diarrhea Headache Patients should consult their healthcare provider if they experience severe or persistent symptoms. Why Choose Cordium Pharmaceuticals Pvt Ltd? ✅ Trusted Indian Pharmaceutical Exporter ✅ Global Oncology Medicine Supply ✅ Competitive Olaparib Tablet Pricing ✅ Support for International Shipments ✅ Supply to Hospitals, Pharmacies & Distributors ✅ Professional Export Documentation Assistance ✅ Reliable Customer Support Frequently Asked Questions (FAQs) 1. What is Olpaza Tablet used for? Olpaza contains Olaparib and is used as a targeted therapy for certain cancers, especially cancers associated with BRCA and DNA repair gene mutations. 2. What strengths of Olpaza Tablets are available? Olpaza Tablets are available in 100mg and 150mg strengths. 3. Can I buy Olpaza Tablets without a prescription? Olaparib is a prescription oncology medicine and should only be used under the supervision of a qualified oncologist. 4. Does Cordium Pharmaceuticals export Olpaza Tablets? Yes, Cordium Pharmaceuticals Pvt Ltd supplies oncology medicines internationally to authorized buyers and healthcare suppliers. 5. How can I order Olpaza Tablets for UAE, UK, or South Africa? You can contact Cordium Pharmaceuticals Pvt Ltd for pricing, availability, and export requirements.